Title: Speman (Himalaya Herbals) – 60 Tablets for Male Fertility, Prostate Health, and Erectile Dysfunction
Description:
Experiencing premature ejaculation, spontaneous spermatorrhea, or reduced sexual performance? Struggling with age-related sexual dysfunction, oligospermia (low sperm count), or low sperm motility? Having difficulty conceiving? Speman, from Himalaya Herbals, may offer a solution.
Speman is an Ayurvedic formulation containing 15 herbs, working synergistically to address various men’s health concerns. It helps prevent and manage acute and chronic prostatitis, benign prostatic hyperplasia (BPH), and male infertility, often stemming from oligospermia. Speman positively influences the higher nerve centers responsible for erection, reducing over-excitement in the spinal cord’s sexual centers. It helps calm sexual anxiety without diminishing potency. This powerful tonic also provides general strengthening benefits, especially helpful after illness or nervous exhaustion.
Speman’s pharmacological action involves:
- Stimulating spermatogenesis
- Enhancing sperm motility
- Reducing sperm viscosity
- Relieving prostate congestion
- Improving urinary symptoms associated with benign prostatic enlargement
With Speman, you may experience normalized ejaculation, increased sexual performance, and improved chances of conception.
Declaration of Conformity:
VP RU Д-IN.PA01.А. 58671/24 from 17.07.2024 to 15.01.2025
Beyond Speman:
Explore our range of men’s health products, including Kapikachhu (for reproductive health) and Himcolin Gel (for erectile dysfunction), also from Himalaya Herbals.
Keywords:
Speman, Himalaya Herbals, male infertility, oligospermia, low sperm count, low sperm motility, premature ejaculation, spermatorrhea, erectile dysfunction, sexual dysfunction, prostatitis, BPH, benign prostatic hyperplasia, men’s health, Ayurvedic medicine, herbal supplement, Kapikachhu, Himcolin, improved fertility, conception, sexual performance, spermatogenesis, sperm motility, prostate health.
Reviews
There are no reviews yet.